TY - JOUR
T1 - Educational intervention to improve quality of care in Barrett's esophagus
T2 - the AQUIRE randomized controlled trial
AU - Parasa, Sravanthi
AU - Wallace, Michael B.
AU - Srinivasan, Sachin
AU - Sundaram, Suneha
AU - Kennedy, Kevin F.
AU - Williams, Lucas J.
AU - Sharma, Prateek
N1 - Funding Information:
DISCLOSURE: The following authors disclosed financial relationships: S. Parasa: Advisory board member and consultant for Fujifilm; consultant for Medtronic; advisory board member for Allen Institute for Artificial Intelligence. M. Wallace: Research grants from Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, and Cosmo/Aries Pharmaceuticals; stock options from Virgo Inc.; food/beverage from Synergy Pharmaceuticals, Boston Scientific, and Cook Medical; consultant on behalf of Mayo Clinic for GI Supply (2018), Endokey, Endostart, Boston Scientific, Microtek, and Verily. P. Sharma: Consultant for Medtronic, Olympus, Boston Scientific, Fujifilm, and Lumendi; grant support from Ironwood, Erbe, Docbot, Cosmo Pharmaceuticals, and CDx Labs. All other authors disclosed no financial relationships. Research support for this study was provided by University of Kansas Cancer Center Pilot funding.
Funding Information:
DISCLOSURE: The following authors disclosed financial relationships: S. Parasa: Advisory board member for Fujifilm. P. Sharma: Consultant for Medtronic, Olympus, Boston Scientific, Fujifilm, and Lumendi; grant support from Ironwood, Erbe, Docbot, Cosmo Pharmaceuticals, and CDx Labs. All other authors disclosed no financial relationships. Research support for this study was provided by University of Kansas Cancer Center Pilot funding.
Publisher Copyright:
© 2022 American Society for Gastrointestinal Endoscopy
PY - 2022/2
Y1 - 2022/2
N2 - Background and Aims: Despite quality measures in upper endoscopy (EGD) for Barrett's esophagus (BE), considerable variability remains in practice among gastroenterologists. This randomized controlled trial evaluated the role of structured intensive training on the quality of EGD in BE. Methods: In this multicenter study, 8 sites (from the GI Quality Consortium) were cluster randomized (1:1) to receive AQUIRE (A Quality Improvement program in cancer care during Endoscopy) training (intervention) or continue local standard practices (control). The primary outcome was compliance with the Seattle biopsy protocol. Secondary outcomes were change in knowledge of BE detection and sampling assessed by questionnaire and dysplasia detection rate (DDR) before and after completion of the 6-month study period. Results: The intervention sites (n = 4) had 31 gastroenterologists and the control sites (n = 4) had 34. There was a significant improvement in the compliance rates with the Seattle biopsy protocol from baseline to the end of the study in the intervention sites (64.8%-73.2%, P =.002) but not in the control sites (69.5%-69.4%, P =.953). The accurate response rate on the questionnaire at the intervention sites increased from 73% at baseline to 88% after AQUIRE training (difference, 14.8%; standard deviation, 18.7; P =.008). DDR did not change significantly from baseline to 6 months in either the control or intervention groups (P =.06). Conclusions: This study confirms the capacity of a structured educational intervention to improve utilization of a standard biopsy protocol and knowledge of standards of care in BE but without significant change in DDR.
AB - Background and Aims: Despite quality measures in upper endoscopy (EGD) for Barrett's esophagus (BE), considerable variability remains in practice among gastroenterologists. This randomized controlled trial evaluated the role of structured intensive training on the quality of EGD in BE. Methods: In this multicenter study, 8 sites (from the GI Quality Consortium) were cluster randomized (1:1) to receive AQUIRE (A Quality Improvement program in cancer care during Endoscopy) training (intervention) or continue local standard practices (control). The primary outcome was compliance with the Seattle biopsy protocol. Secondary outcomes were change in knowledge of BE detection and sampling assessed by questionnaire and dysplasia detection rate (DDR) before and after completion of the 6-month study period. Results: The intervention sites (n = 4) had 31 gastroenterologists and the control sites (n = 4) had 34. There was a significant improvement in the compliance rates with the Seattle biopsy protocol from baseline to the end of the study in the intervention sites (64.8%-73.2%, P =.002) but not in the control sites (69.5%-69.4%, P =.953). The accurate response rate on the questionnaire at the intervention sites increased from 73% at baseline to 88% after AQUIRE training (difference, 14.8%; standard deviation, 18.7; P =.008). DDR did not change significantly from baseline to 6 months in either the control or intervention groups (P =.06). Conclusions: This study confirms the capacity of a structured educational intervention to improve utilization of a standard biopsy protocol and knowledge of standards of care in BE but without significant change in DDR.
UR - http://www.scopus.com/inward/record.url?scp=85117745781&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117745781&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2021.08.026
DO - 10.1016/j.gie.2021.08.026
M3 - Article
C2 - 34499903
AN - SCOPUS:85117745781
SN - 0016-5107
VL - 95
SP - 239-245.e2
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 2
ER -